AstraZeneca UK Limited

Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003

Patient Information Leaflet last updated on the eMC: 06/12/2011
PIL Symbicort Turbohaler 100/6, Inhalation powder.

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06/12/2011 and displayed until Current
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 24/11/2011 and displayed until 06/12/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to instructions about overdose
Updated on 23/09/2011 and displayed until 24/11/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 15/03/2011 and displayed until 23/09/2011
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration
Updated on 28/04/2010 and displayed until 15/03/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to storage instructions
Updated on 09/01/2009 and displayed until 28/04/2010
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to side-effects
  • Change to information about driving or using machinery
Updated on 29/06/2007 and displayed until 09/01/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 04/06/2007 and displayed until 29/06/2007
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to dosage and administration
Updated on 19/01/2005 and displayed until 04/06/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 31/03/2004 and displayed until 19/01/2005
Reasons for adding or updating:
  • Change to date of revision
Updated on 23/10/2002 and displayed until 31/03/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   budesonide
   formoterol fumarate dihydrate